Ming Shi
Impact in
- Hepatology top 0.1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Ginseng Biological Effects and Applications 16
- Hepatology 73
- Hepatocellular Carcinoma Treatment and Prognosis 69
- Co-authors
- Rong Guo (58 shared papers)Min-Shan Chen (14 shared papers)Wei Wei (31 shared papers)Jian‐Yong Wu (5 shared papers)Yaojun Zhang (13 shared papers)Xiao-Jun Lin (8 shared papers)Li Xu (16 shared papers)Jin-Qing Li (6 shared papers)
- Journals
- PLoS ONE (8 papers)Frontiers in Oncology (5 papers)Chinese Journal of Cancer (4 papers)Frontiers in Immunology (4 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ming Shi
281 papers receiving 8.3k citations
Ming Shi's Hit Papers
Peers
Comparison fields: 5 of 165
- Hepatology 3.1k
- Cancer Research 885
- Complementary and alternative medicine 362
- Neurology 279
- Developmental Neuroscience 133
Countries citing papers authored by Ming Shi
This map shows the geographic impact of Ming Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Shi more than expected).
Fields of papers citing papers by Ming Shi
This network shows the impact of papers produced by Ming Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Shi. The network helps show where Ming Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 294 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion Hit paper breakdown → | 2019 | 386 |
| 2 | 2006 | 377 | |
| 3 | 2010 | 278 | |
| 4 | 2018 | 204 | |
| 5 | 2008 | 196 | |
| 6 | 2012 | 175 | |
| 7 | 2006 | 168 | |
| 8 | 2004 | 148 | |
| 9 | 2021 | 146 | |
| 10 | 2018 | 124 | |
| 11 | Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial Hit paper breakdown → | 2022 | 122 |
| 12 | 2010 | 116 | |
| 13 | 2016 | 108 | |
| 14 | 2017 | 106 | |
| 15 | 2015 | 105 | |
| 16 | 2009 | 103 | |
| 17 | 2011 | 97 | |
| 18 | 2011 | 97 | |
| 19 | 2016 | 93 | |
| 20 | 2013 | 88 |
About Ming Shi
Ming Shi is a scholar working on Molecular Biology, Hepatology, Surgery, Epidemiology and Pathology and Forensic Medicine, having authored 294 papers that have together received 8.4k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (69 papers), Ginseng Biological Effects and Applications (16 papers), Cancer Mechanisms and Therapy (14 papers), Neurogenesis and neuroplasticity mechanisms (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Traditional Chinese Medicine Analysis (9 papers), Neuroinflammation and Neurodegeneration Mechanisms (9 papers) and Hepatitis B Virus Studies (7 papers). The work is most often cited by research in Hepatology (3.1k citations), Cancer Research (885 citations), Complementary and alternative medicine (362 citations), Neurology (279 citations) and Developmental Neuroscience (133 citations). Ming Shi has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Rong Guo, Min-Shan Chen, Wei Wei, Jian‐Yong Wu, Yaojun Zhang, Xiao-Jun Lin, Li Xu, Jin-Qing Li, Wan Yee Lau and Minke He. Their work appears in journals such as PLoS ONE, Frontiers in Oncology, Chinese Journal of Cancer, Frontiers in Immunology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.